Rapport Therapeutics, Inc. RAPP
Set alert
25.39 USD +0.26 +1.01%
As of Nov 3, 2:07 PM ET
25.13 Day range 26.06
22.06 52-week range 52.93
- YTD
- -16.33%
- 1 year
- -5.77%
- Open
- 25.39
- Prev close
- 25.13
- Mkt cap
- 1.47B
- Vol
- 324.01K
- Avg vol
- 712.76K
- EPS
- -3.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.13
- High
- 26.06
- Forward P/E
- -4.94
- Beta
- 1.40
- Short ratio
- 6.70
- Inst. own
- 96.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 36.70
- 200-d avg
- 35.65
- 1y target
- 68.29
5D chart
Signals (139)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 3:30 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:45 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:45 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:35 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:30 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:30 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:20 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 12:55 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 12:45 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:20 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:15 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:10 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 11:50 AM | 1 day ago |
| SMA: Bullish | Nov 2, 11:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:40 AM | 1 day ago |
Newest 20 of 139.
Financial health
Altman Z-Score
19.18 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -10.6×
FY 2022 5y median -16.3× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 2.9×
FY 2022 5y median 2.1× FY 2025
P/FCF -16.2×
FY 2022 5y median -14.6× FY 2025
EV/EBITDA -11.2×
FY 2022 5y median -9.8× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -6.2%
FY 2022 5y median -6.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -23.0%
FY 2022 5y median -24.3% FY 2025
ROIC -25.2%
FY 2022 5y median -26.1% FY 2025
ROA -21.8%
FY 2022 5y median -23.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -50.6%
FY 2022 FY 2025
EPS (diluted) 24.3%
FY 2022 FY 2025
Free Cash Flow -31.0%
FY 2022 FY 2025
Financial Health
Current Ratio 26.2×
FY 2022 5y median 22.5× FY 2025
Quick Ratio 26.2×
FY 2022 5y median 22.5× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2022 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31